首页> 外文会议>International Symposium on Biological and Medical Data Analysis(ISBMDA 2004) >Bayesian Prediction of Down Syndrome Based on Maternal Age and Four Serum Markers
【24h】

Bayesian Prediction of Down Syndrome Based on Maternal Age and Four Serum Markers

机译:基于产妇年龄和四种血清标记的贝叶斯预测唐氏综合征

获取原文

摘要

Screening tests have been designed to identify women at increased risk of having a Down syndrome pregnancy. These tests have no risks of miscarriage, but they are not able to determine with certainty whether a fetus is affected. Diagnostic tests such as amniocentesis, on the other hand, are extremely accurate at identifying abnormalities in the fetus, but carry some risk of miscarriage, making it inappropriate to examine every pregnancy in this way. Muller et al.(1999), compares six software packages that calculate Ds risk, concluding that substantial variations are observed among them. In this paper, we provide a Bayesian reanalysis of the current quadruple screening test, based on maternal age and four serum markers (afp, uE3, hCG and DIA), which suggests the need to reevaluate more carefully actual recomendations.
机译:筛选测试旨在识别患有唐氏综合症怀孕的风险增加的女性。 这些测试没有流产的风险,但它们无法确定胎儿是否受到影响。 另一方面,血管穿刺术等诊断测试在识别胎儿的异常时非常准确,但携带一些流产的风险,使它以这种方式检查每次怀孕。 Muller等人。(1999),比较了计算DS风险的六个软件包,结论是在其中观察到实质性变化。 在本文中,我们提供了基于母体年龄和四种血清标记(AFP,UE3,HCG和Dia)的当前四点筛选试验的贝叶斯再分析,这表明需要更仔细地重新评估实际的重新调整。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号